CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $112M invested in Cymabay Therapeutics in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
-24
Holders Change %
-17.52%
% of All Funds
2.23%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
27
Increased
34
Reduced
31
Closed
46
Calls
$930K
Puts
$55K
Net Calls
+$875K
Net Calls Change
-$4.66M
Top Buyers
| 1 |
ECM
Engine Capital Management
New York
|
$9.77M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
$10.8M |
| 3 |
Morgan Stanley
New York
|
$4.77M |
| 4 |
D.E. Shaw & Co
New York
|
$3.96M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
$3.92M |
